1. Siegel, RL, Miller, KD, Jemal, A. Cancer statistics, 2015. CA Cancer J Clin. 2015 Feb 1;65(1):5–29.
Google Scholar | Crossref | Medline2. Legué, LM, Bernards, N, Gerritse, SL, van Oudheusden, TR, de Hingh, IH, Creemers, GM, Ten Tije, AJ, Lemmens, VE. Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in the Netherlands. Acta Oncol. 2016 Oct 1;55(9–10):1183–9.
Google Scholar | Crossref3. Lu, Y, Fröbom, R, Lagergren, J. Incidence patterns of small bowel cancer in a population-based study in Sweden: increase in duodenal adenocarcinoma. Cancer Epidemiol. 2012 Jun 1;36(3):e158–63.
Google Scholar | Crossref4. Onkendi, EO, Boostrom, SY, Sarr, MG, Farnell, MB, Nagorney, DM, Donohue, JH, Kendrick, ML, Reid-Lombardo, KM, Harmsen, WS, Que, FG. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas. J Gastrointest Surg. 2012 Apr 1;16(4):682–91.
Google Scholar | Crossref5. Poultsides, GA, Huang, LC, Cameron, JL, Tuli, R, Lan, L, Hruban, RH, Pawlik, TM, Herman, JM, Edil, BH, Ahuja, N, Choti, MA, Wolfgang, CL, Schulick, RD. Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment. Ann Surg Oncol. 2012 Jun 1;19(6):1928–35.
Google Scholar | Crossref6. Struck, A, Howard, T, Chiorean, EG, Clarke, JM, Riffenburgh, R, Cardenes, HR. Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival. J Surg Oncol. 2009 Aug 1;100(2):144–8.
Google Scholar | Crossref7. Williams, JL, Chan, CK, Toste, PA, Elliott, IA, Vasquez, CR, Sunjaya, DB, Swanson, EA, Koo, J, Hines, OJ, Reber, HA, Dawson, DW, Donahue, TR. Association of histopathologic phenotype of periampullary adenocarcinomas with survival. JAMA Surg. 2017 Jan 1;152(1):82–8.
Google Scholar | Crossref8. Pastorekova, S, Parkkila, S, Pastorek, J, Supuran, CT. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem. 2004 Jun 1;19(3):199–229.
Google Scholar | Crossref9. Supuran, CT . Structure and function of carbonic anhydrases. Biochem J. 2016 Jul 15;473(14):2023–32.
Google Scholar | Crossref10. Warburg, O . On respiratory impairment in cancer cells. Science. 1956 Aug 10;124(3215):269–70.
Google Scholar | Crossref11. Parks, SK, Cormerais, Y, Pouysségur, J. Hypoxia and cellular metabolism in tumour pathophysiology. J Physiol. 2017 Apr 15;595(8):2439–50.
Google Scholar | Crossref12. Swietach, P, Vaughan-Jones, RD, Harris, AL, Hulikova, A. The chemistry, physiology and pathology of pH in cancer. Philos Trans R Soc Lond B Biol Sci. 2014 Feb 3;369(1638):20130099.
Google Scholar | Crossref13. Svastova, E, Hulikova, A, Rafajova, M, Zat’ovicova, M, Gibadulinova, A, Casini, A, Cecchi, A, Scozzafava, A, Supuran, CT, Pastorek, J, Pastorekova, S. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett. 2004 Nov 19;577(3):439–45.
Google Scholar | Crossref14. Gatenby, RA, Gillies, RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004 Nov 1;4(11):891–9.
Google Scholar | Crossref15. Becker, HM, Klier, M, Schuler, C, McKenna, R, Deitmer, JW. Intramolecular proton shuttle supports not only catalytic but also noncatalytic function of carbonic anhydrase II. Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3071–6.
Google Scholar | Crossref16. Counillon, L, Bouret, Y, Marchiq, I, Pouysségur, J. Na(+)/H(+) antiporter (NHE1) and lactate/H(+) symporters (MCTs) in pH homeostasis and cancer metabolism. Biochim Biophys Acta. 2016 Oct 1;1863(10):2465–80.
Google Scholar17. Chiche, J, Ilc, K, Laferriere, J, Trottier, E, Dayan, F, Mazure, NM, Brahimi-Horn, MC, Pouyssegur, J. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res. 2009 Jan 1;69(1):358–68.
Google Scholar | Crossref18. Kivela, AJ, Kivela, J, Saarnio, J, Parkkila, S. Carbonic anhydrases in normal gastrointestinal tract and gastrointestinal tumours. World J Gastroenterol. 2005 Jan 14;11(2):155–63.
Google Scholar | Crossref19. Leppilampi, M, Parkkila, S, Karttunen, T, Gut, MO, Gros, G, Sjöblom, M. Carbonic anhydrase isozyme-II-deficient mice lack the duodenal bicarbonate secretory response to prostaglandin E2. Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15247–52.
Google Scholar | Crossref20. Sjöblom, M, Singh, AK, Zheng, W, Wang, J, Tuo, BG, Krabbenhöft, A, Riederer, B, Gros, G, Seidler, U. Duodenal acidity “sensing” but not epithelial HCO3- supply is critically dependent on carbonic anhydrase II expression. Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13094–9.
Google Scholar | Crossref21. Hu, X, Huang, Z, Liao, Z, He, C, Fang, X. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients. Int J Clin Exp Pathol. 2014 Sep 15;7(10):6716–24.
Google Scholar22. Sheng, W, Dong, M, Zhou, J, Li, X, Dong, Q. Down regulation of CAII is associated with tumor differentiation and poor prognosis in patients with pancreatic cancer. J Surg Oncol. 2013 Apr 1;107(5):536–43.
Google Scholar | Crossref23. Saarnio, J, Parkkila, S, Parkkila, AK, Waheed, A, Casey, MC, Zhou, XY, Pastoreková, S, Pastorek, J, Karttunen, T, Haukipuro, K, Kairaluoma, MI, Sly, WS. Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity. J Histochem Cytochem. 1998 Apr 1;46(4):497–504.
Google Scholar | SAGE Journals24. van Kuijk, SJ, Yaromina, A, Houben, R, Niemans, R, Lambin, P, Dubois, LJ. Prognostic significance of carbonic anhydrase IX expression in cancer patients: a meta-analysis. Front Oncol. 2016 Mar 29;6:69.
Google Scholar | Crossref25. Jin, MS, Lee, H, Park, IA, Chung, YR, Im, SA, Lee, KH, Moon, HG, Han, W, Kim, K, Kim, TY, Noh, DY, Ryu, HS. Overexpression of HIF1alpha and CAXI predicts poor outcome in early-stage triple negative breast cancer. Virchows Arch. 2016 Aug 1;469(2):183–90.
Google Scholar | Crossref26. Senol, S, Aydin, A, Kosemetin, D, Ece, D, Akalin, I, Abuoglu, H, Duran, EA, Aydin, D, Erkol, B. Gastric adenocarcinoma biomarker expression profiles and their prognostic value. J Environ Pathol Toxicol Oncol. 2016;35(3):207–22.
Google Scholar | Crossref27. Birner, P, Jesch, B, Friedrich, J, Riegler, M, Zacherl, J, Hejna, M, Wrba, F, Schultheis, A, Schoppmann, SF. Carbonic anhydrase IX overexpression is associated with diminished prognosis in esophageal cancer and correlates with her-2 expression. Ann Surg Oncol. 2011 Nov 1;18(12):3330–7.
Google Scholar | Crossref28. Karhumaa, P, Parkkila, S, Tureci, O, Waheed, A, Grubb, JH, Shah, G, Parkkila, A, Kaunisto, K, Tapanainen, J, Sly, WS, Rajaniemi, H. Identification of carbonic anhydrase XII as the membrane isozyme expressed in the normal human endometrial epithelium. Mol Hum Reprod. 2000 Jan 1;6(1):68–74.
Google Scholar | Crossref29. Parkkila, S, Parkkila, AK, Saarnio, J, Kivelä, J, Karttunen, TJ, Kaunisto, K, Waheed, A, Sly, WS, Türeci, O, Virtanen, I, Rajaniemi, H. Expression of the membrane-associated carbonic anhydrase isozyme XII in the human kidney and renal tumors. J Histochem Cytochem. 2000 Dec 1;48(12):1601–8.
Google Scholar | SAGE Journals30. Kivelä, A, Parkkila, S, Saarnio, J, Karttunen, TJ, Kivelä, J, Parkkila, AK, Waheed, A, Sly, WS, Grubb, JH, Shah, G, Türeci, O, Rajaniemi, H. Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors. Am J Pathol. 2000 Feb 1;156(2):577–84.
Google Scholar | Crossref31. Waheed, A, Sly, WS. Carbonic anhydrase XII functions in health and disease. Gene. 2017 Aug 5;623:33–40.
Google Scholar | Crossref32. Chien, MH, Ying, TH, Hsieh, YH, Lin, CH, Shih, CH, Wei, LH, Yang, SF. Tumor-associated carbonic anhydrase XII is linked to the growth of primary oral squamous cell carcinoma and its poor prognosis. Oral Oncol. 2012 May 1;48(5):417–23.
Google Scholar | Crossref33. Ochi, F, Shiozaki, A, Ichikawa, D, Fujiwara, H, Nakashima, S, Takemoto, K, Kosuga, T, Konishi, H, Komatsu, S, Okamoto, K, Kishimoto, M, Marunaka, Y, Otsuji, E. Carbonic anhydrase XII as an independent prognostic factor in advanced esophageal squamous cell carcinoma. J Cancer. 2015 Jul 29;6(10):922–9.
Google Scholar | Crossref34. Gu, XF, Shi, CB, Zhao, W. Prognostic value of carbonic anhydrase XII (CA XII) overexpression in hepatocellular carcinoma. Int J Clin Exp Pathol. 2019 Jun 1;12(6):2173–83.
Google Scholar35. Lim, CH, Cho, YS. Nonampullary duodenal adenoma: current understanding of its diagnosis, pathogenesis, and clinical management. World J Gastroenterol. 2016 Jan 14;22(2):853–61.
Google Scholar | Crossref36. Sellner, F . Investigations on the significance of the adenoma-carcinoma sequence in the small bowel. Cancer. 1990 Aug 15;66(4):702–15.
Google Scholar | Crossref37. Gu, MJ, Kwon, KW. Carbonic anhydrase IX expression is associated with favorable prognostic factors in small intestinal carcinoma. J Histochem Cytochem. 2014 Mar 1;62(3):205–10.
Google Scholar | SAGE Journals38. Ullah, MS, Davies, AJ, Halestrap, AP. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem. 2006 Apr 1;281(14):9030–7.
Google Scholar | Crossref39. Ebert, BL, Firth, JD, Ratcliffe, PJ. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences. J Biol Chem. 1995 Dec 8;270(49):29083–9.
Google Scholar | Crossref40. Amin, MB, Edge, S, Greene, F, Byrd, DR, Brookland, RK, Washington, MK, Gershenwald, JE, Compton, CC, Hess, KR, Sullivan, DC, Jessup, JM, Brierley, JD, Gaspar, LE, Schilsky, RL, Balch, CM, Winchester, DP, Asare, EA, Madera, M, Gress, DM, Meyer, LR editors. AJCC cancer staging manual . 8th ed. New York: Springer International Publishing; 2017.
Google Scholar41. WHO Classification of Tumours Editorial Board 2019, editor. Digestive system tumours WHO classification of tumours. 5th ed., vol. 1. Lyon: IARC Publications; 2019.
Google Scholar42. Viikila, P, Kivela, AJ, Mustonen, H, Koskensalo, S, Waheed, A, Sly, WS, Pastorek, J, Pastorekova, S, Parkkila, S, Haglund, C. Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas. World J Gastroenterol. 2016 Sep 28;22(36):8168–77.
Google Scholar | Crossref43. Parkkila, AK, Parkkila, S, Juvonen, T, Rajaniemi, H. Carbonic anhydrase isoenzymes II and I are present in the zona glomerulosa cells of the human adrenal gland. Histochemistry. 1993 Jan 1;99(1):37–41.
Google Scholar | Crossref44. Pastorekova, S, Parkkila, S, Parkkila, AK, Opavsky, R, Zelnik, V, Saarnio, J, Pastorek, J. Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. Gastroenterology. 1997 Feb 1;112(2):398–408.
Google Scholar | Crossref45. Huhta, H, Helminen, O, Palomaki, S, Kauppila, JH, Saarnio, J, Lehenkari, PP, Karttunen, TJ. Intratumoral lactate metabolism in Barrett’s esophagus and adenocarcinoma. Oncotarget. 2017 Apr 4;8(14):22894–902.
Google Scholar | Crossref46. Kauppila, JH, Takala, H, Selander, KS, Lehenkari, PP, Saarnio, J, Karttunen, TJ. Increased toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma. Histopathology. 2011 Oct 1;59(4):643–9.
Google Scholar | Crossref47. McHugh, ML . Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276–82.
Google Scholar | Medline48. Parkkila, S, Parkkila, AK, Juvonen, T, Rajaniemi, H. Distribution of the carbonic anhydrase isoenzymes I, II, and VI in the human alimentary tract. Gut. 1994 May 1;35(5):646–50.
Google Scholar | Crossref49. Mizumori, M, Meyerowitz, J, Takeuchi, T, Lim, S, Lee, P, Supuran, CT, Guth, PH, Engel, E, Kaunitz, JD, Akiba, Y. Epithelial carbonic anhydrases facilitate PCO2 and pH regulation in rat duodenal mucosa. J Physiol. 2006 Jun 15;573(Pt 3):827–42.
Google Scholar50. Akiba, Y, Kaunitz, JD. Duodenal chemosensing and mucosal defenses. Digestion. 2011;83(Suppl 1):25–31.
Google Scholar | Crossref51. Akiba, Y, Ghayouri, S, Takeuchi, T, Mizumori, M, Guth, PH, Engel, E, Swenson, ER, Kaunitz, JD. Carbonic anhydrases and mucosal vanilloid receptors help mediate the hyperemic response to luminal CO2 in rat duodenum. Gastroenterology. 2006 Jul 1;131(1):142–52.
Google Scholar | Crossref52. Kaunitz, JD, Akiba, Y. Duodenal carbonic anhydrase: mucosal protection, luminal chemosensing, and gastric acid disposal. Keio J Med. 2006 Sep 1;55(3):96–106.
Google Scholar | Crossref53. Saarnio, J, Parkkila, S, Parkkila, AK, Haukipuro, K, Pastorekova, S, Pastorek, J, Kairaluoma, MI, Karttunen, TJ. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol. 1998 Jul 1;153(1):279–85.
Google Scholar | Crossref54. Leppilampi, M, Karttunen, TJ, Kivelä, J, Gut, MO, Pastoreková, S, Pastorek, J, Parkkila, S. Gastric pit cell hyperplasia and glandular atrophy in carbonic anhydrase IX knockout mice: studies on two strains C57/BL6 and BALB/C. Transgenic Res. 2005 Oct 1;14(5):655–63.
Google Scholar | Crossref55. Gut, MO, Parkkila, S, Vernerova, Z, Rohde, E, Zavada, J, Hocker, M, Pastorek, J, Karttunen, T, Gibadulinova, A, Zavadova, Z, Knobeloch, KP, Wiedenmann, B, Svoboda, J, Horak, I, Pastorekova, S. Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9. Gastroenterology. 2002 Dec 1;123(6):1889–903.